Publication | Closed Access
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial
140
Citations
18
References
2022
Year
Bone SarcomasSurgical OncologyMetastatic Soft TissueMedicineSingle-centre Phase 2PathologyImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyTumor Biology
| Year | Citations | |
|---|---|---|
Page 1
Page 1